Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

All3 Global AG

History from 22 May 2025

UID
CHE-327.335.653
Legal form
AG
Canton
ZG
Founded
22 May 2025
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 154k
39k77k116k154k15 Apr 2026 · CHF 146k22 Jun 2026 · CHF 154k
  • shares
  • Vorzugsaktien

Record

  1. Company formed

    Founded 22 May 2025

    SHAB HR01-1006341942 ↗
  2. Capital increase

    Likely financing

    Paid in cash and by other means

    Nominal capital
    100’000 → 146’058
    Shares
    100’000 → 146’058
    New shares, % of post-step shares
    31.5% (46’058 new)
    Share classes
    100’000 × CHF 1 · 46’058 × CHF 1 Vorzugsaktien

    Aktienkapital neu: CHF 146'058.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 146'058.00 [bisher: CHF 100'000.00]. Aktien neu: 100'000 vinkulierte Namenaktien zu CHF 1.00 und 46'058 vinkulierte Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 100'000 Namenaktien zu CHF 1.00]. Kapitalband gemäss näherer Umschreibung in den Statuten. Vinkulierung neu: Die Übertragbarkeit der Namenaktien ist nach Massgabe der Statuten beschränkt.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.93 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006625302 ↗
  3. Capital band adopted

    SHAB HR02-1006625302 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    146’058 → 154’283
    Shares
    146’058 → 154’283
    New shares, % of post-step shares
    5.3% (8’225 new)
    Share classes
    100’000 × CHF 1 · 54’283 × CHF 1 Vorzugsaktien

    Aktienkapital neu: CHF 154'283.00 [bisher: CHF 146'058.00]. Liberierung Aktienkapital neu: CHF 154'283.00 [bisher: CHF 146'058.00]. Aktien neu: 100'000 vinkulierte Namenaktien zu CHF 1.00 und 54'283 vinkulierte Namenaktien zu CHF 1.00 (Vorzugsaktien) [bisher: 46'058 vinkulierte Namenaktien zu CHF 1.00 (Vorzugsaktien) und 100'000 vinkulierte Namenaktien zu CHF 1.00]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes. [gestrichen: Kapitalband gemäss näherer Umschreibung in den Statuten.]

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006683890 ↗
  5. Capital band adopted

    SHAB HR02-1006683890 ↗

Published by 28 Jun 2026

Latest available record · 8 Oct 2026